Duane Sinead, Beecher Claire, Vellinga Akke, Murphy Andrew W, Cormican Martin, Smyth Andrew, Healy Patricia, Moore Michael, Little Paul, Devane Declan
Discipline of Marketing, J. E. Cairnes School of Business and Economics, National University of Ireland Galway, Galway, Ireland.
HRB TMRN, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
JAC Antimicrob Resist. 2022 Mar 22;4(2):dlac025. doi: 10.1093/jacamr/dlac025. eCollection 2022 Apr.
Uncomplicated urinary tract infections (UTIs) are amongst the most frequent infections presenting in the outpatient setting. A growing number of clinical trials are assessing the most effective treatment interventions for uncomplicated UTI. Due to the heterogeneity of the outcomes reported in these trials, however, comparing these outcomes is challenging.
Identify the core outcomes that have been reported in trials and systematic reviews of interventions treating uncomplicated UTI in adults.
We conducted a systematic search for core outcomes used to evaluate treatments of UTIs. We searched the Cochrane Database of Systematic Reviews, PubMed and Embase. One researcher independently screened each article for inclusion, and the Core Outcome Set for treatment of Urinary Tract Infections (COSUTI) team acted as second reviewers. All included articles were screened by two reviewers. All outcomes were extracted verbatim, and similar outcomes were grouped into domains and subdomains.
In total, 334 outcomes were reported across 41 papers, the average number of outcomes reported being 8. Outcomes were categorized across 18 domains, the majority of which were related to clinical cure outcomes. Many outcomes varied in the timepoints within which the outcome was measured and reported.
Comparing the outcomes of trials investigating uncomplicated UTI treatment remains challenging due to the difference in outcomes currently reported. Consistency of reporting of outcomes would be improved by developing a minimum number of consistent outcomes that should be reported in all trials.
单纯性尿路感染(UTIs)是门诊中最常见的感染之一。越来越多的临床试验正在评估单纯性UTI最有效的治疗干预措施。然而,由于这些试验报告的结果存在异质性,比较这些结果具有挑战性。
确定在治疗成人单纯性UTI的干预措施的试验和系统评价中报告的核心结果。
我们对用于评估UTIs治疗的核心结果进行了系统检索。我们检索了Cochrane系统评价数据库、PubMed和Embase。一名研究人员独立筛选每篇文章以确定是否纳入,尿路感染治疗核心结局集(COSUTI)团队作为第二评审员。所有纳入的文章均由两名评审员进行筛选。所有结果均逐字提取,相似的结果被归入不同的领域和子领域。
41篇论文共报告了334个结果,平均每篇论文报告的结果数为8个。结果分为18个领域,其中大多数与临床治愈结果相关。许多结果在测量和报告结果的时间点上有所不同。
由于目前报告的结果存在差异,比较单纯性UTI治疗试验的结果仍然具有挑战性。通过制定所有试验都应报告的最少数量的一致结果,可提高结果报告的一致性。